Q1 2020 Biopharma Market Conditions Report Live Panel – April 16, 2020
Q1 2020 Biopharma Market Conditions Report Live Panel – April 16, 2020
Locust Walk Webinar
Locust Walk Webinar
Fundamentals and Recent Trends in Life Sciences Private Financing – March 15, 2018
Fundamentals and Recent Trends in Life Sciences Private Financing- webinar Fundamentals and Recent Trends in Life Sciences Private Financing- webinar
Locust Walk Webinar
BioPharma Partnering in Japan – December 18, 2017
Biopharma Partnering in Japan Biopharma Partnering in Japan This half an hour webinar will provide valuable education and insights into
Locust Walk Webinar
Life Science Financing Term Sheet Review- October 17, 2017
Webinar- Life Science Financing Term Sheet Webinar- Life Science Financing Term Sheet The webinar will be a comprehensive overview of
Locust Walk Webinar
BioPharma Sell-Side Deal Process Keys to Success – May 3, 2017
Webinar-BioPharma Sell-Side Deal Process Keys to Success Webinar-BioPharma Sell-Side Deal Process Keys to Success This one-hour, interactive webinar will provide
Locust Walk Webinar
BioPharma Buy-Side Deal Process Keys to Success- June 13, 2017
BioPharma Buy-Side Deal Process Keys to Success BioPharma Buy-Side Deal Process Keys to Success The webinar will cover key issues
Locust Walk Webinar
Fundamentals and Key Trends in Life Sciences Private Financing- July 26, 2017
Fundamentals And Recent Trends in Life Sciences Private Financing Fundamentals And Recent Trends in Life Sciences Private Financing This one-hour,
Locust Walk Webinar
Biopharma Valuation Analysis
Webinar- Biopharma Valuation Analysis Biopharma Valuation Analysis The webinar will cover key issues surrounding how to best value a biopharma
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing